GSK1292263
GSK1292263 is a novel potent, selective GPR119 agonist, elevates circulating glucose-dependent insulinotropic peptide, GLP-1 and peptide tyrosine-tyrosine in nonclinical models of diabetes, with no effect on plasma glucose.Dyslipidemia Phase 2 Discontinued (In Vivo) :GSK1292263 upregulates glucagon-like peptide-1 and enhances glucose-dependent insulin secretion and improves glucose homeostasis in type 2 diabetic rats.
Product Specifications
CAS Number
1032823-75-8
Product Name Alternative
GSK 1292263 | GSK-1292263
Purity
>98% (HPLC)
Solubility
DMSO: ≥ 30 mg/mL
Smiles
O=S (C1=CC=C (C2=CC=C (OCC3CCN (C4=NC (C (C) C) =NO4) CC3) C=N2) C=C1) (C) =O
Molecular Formula
C23H28N4O4S
Molecular Weight
456.5578
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Pyridine, 5-[[1-[3- (1-methylethyl) -1,2,4-oxadiazol-5-yl]-4-piperidinyl]methoxy]-2-[4- (methylsulfonyl) phenyl]-
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
F(ab')2 Goat IgG (H&L) Antibody Peroxidase Conjugated
PE-Linked Monoclonal Antibody to Apolipoprotein A5 (APOA5)
